GHS Classification Guidance for the Japanese Government
GHS Classification Guidance for the Japanese Government
GHS Classification Guidance for the Japanese Government
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
*As <strong>for</strong> substances of which only mixture data are available (provided mixed or diluted<br />
with solvents without toxicity), <strong>the</strong>ir <strong>GHS</strong> classification as pure substances are<br />
per<strong>for</strong>med by estimating from concentrations appropriately, and <strong>the</strong> estimation<br />
processes are to be described as a ground <strong>for</strong> classification.<br />
B) Regarding classification procedure<br />
1) Substances meeting [Decision criteria 1a] or [Decision criteria 1b] below are placed in<br />
Category 1.<br />
[Decision criteria 1a]: Substances <strong>for</strong> which evidence of inducing toxic effects in humans are<br />
(Notes)<br />
available in List 1.<br />
a) Effects on organs that are obviously known to be secondary effects shall be excluded<br />
from <strong>the</strong> description. Judgement by expert’s shall be sought <strong>for</strong> where necessary about<br />
whe<strong>the</strong>r <strong>the</strong> effects are secondary effects or not. When such a judgment is difficult, all<br />
organs affected shall be cited.<br />
b) Effects on respiratory system by site of contact are included here, and are placed in<br />
Category 1 (pneumoconiosis, etc.). However, such effects by site of contact o<strong>the</strong>r than<br />
respiratory tract, <strong>for</strong> example, irritation/inflammation reaction in digestive system in a<br />
case of oral administration of a corrosive/irritant, are considered to be subsumed under<br />
o<strong>the</strong>r toxicity items such as skin corrosion and are not classified into specific target<br />
organ.<br />
c) When only minimal symptoms (slight fever, languor, etc.)are described, <strong>the</strong> substance is<br />
placed in “Not classified”.<br />
d) All organs described as affected in List 1 shall be indicated. However, when organs<br />
listed in multiple assessment documents based on <strong>the</strong> same type of tests are not <strong>the</strong><br />
same, indicate <strong>the</strong> commonly listed organs. When a toxic symptom alone is described<br />
and <strong>the</strong> affected organ cannot be identified, put “systemic toxicity” instead. When <strong>the</strong><br />
target organ is identified, fundamentally, description of toxic symptom is not required.<br />
e) When <strong>the</strong> affected organ can be identified, indicate <strong>the</strong> applicable category along with<br />
<strong>the</strong> affected organs given in paren<strong>the</strong>ses are indicated in “<strong>GHS</strong> classification”. When <strong>the</strong><br />
affected organ cannot be identified, put “systemic toxicity” in paren<strong>the</strong>ses.<br />
[Decision criteria 1b]: Animal tests meeting all of conditions below<br />
a) Any animal species is applicable<br />
b) Exposure amount is identified and is induced within <strong>the</strong> guidance value range of<br />
Category 1<br />
c) The test is described in List 1 or an OECD TG test in List 2, is according to GLP, and<br />
185